Navigation Links
SCOLR Pharma, Inc. Announces Second Quarter 2011 Financial Results
Date:7/26/2011

p>

For the quarter ended June 30, 2011, the Company's marketing and selling expenses decreased 38%, or $33,000, to $53,000, compared to $86,000 for the same period in 2010.  This decrease was primarily due to a reduction in sales commissions and royalties due to lower royalty revenues.

The Company recorded a gain of $103,000 on research and development activity compared to an expense of $256,000 for the same period in 2010.  The gain was a result of receiving proceeds during the quarter on sale of certain laboratory equipment of $120,000, combined with lower research and development expenses following the elimination of its laboratory activities.

General and administrative expenses increased 2%, or $13,000, to $585,000 for the three months ended June 30, 2011, compared to approximately $572,000 for the same period in 2010.   The increase was primarily due to recognition of $61,000 in accelerated depreciation expense related to leasehold improvements as a result of a reduction in the term of our headquarters lease. This increase was offset by a decrease in office expense.

Other income decreased 106%, or $222,000, to an expense of $12,000 for the three months ended June 30, 2011, compared to income of $210,000 for the comparable period in 2010. This decrease is due to a change in unrealized gain (loss) on the fair value of a warrant to purchase common stock.  

Net loss increased 12%, or $58,000, to $539,000 for the three months ended June 30, 2011, compared to $481,000 for the same period in 2010. The increase in net loss reflects lower revenues and the change in the unrealized gain (loss) on fair value of warrant to purchase common stock.

Comparison of the Year to Date Six Months Ended June 30, 2011 and 2010 Total revenues, which consist of licensing fees, research and development revenues, and royalty revenue from SCOLR's collaboration agreements, decreased 51%, or $197,000, to $192,000 for the si
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. SCOLR Pharma, Inc. First Quarter 2011 Financial Results
2. SCOLR Pharma, Inc. to Present at Taglich Brothers 8th Annual Small Cap Equity Conference
3. SCOLR Pharma, Inc. Reports 2010 Financial Results, Provides Updates on Advances in Nutritionals, OTC Drugs
4. SCOLR Pharma, Inc. Receives Deficiency Letter from FDA on Pseudoephedrine Application
5. SCOLR Pharma, Inc. Retains Nicholas Hall & Company
6. SCOLR Pharma, Inc. Common Stock to Begin Trading on OTC Bulletin Board and OTCQB Stock Market on January 13, 2011
7. SCOLR Pharma, Inc. Announces Intention to Voluntarily Delist From NYSE AMEX Exchange
8. SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
9. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
10. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
11. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... PHILADELPHIA , 22. Mai 2013 /PRNewswire/ ... Sitz in Barcelona , ... aufzeigt, dass eine höhere Dosis von PROLASTIN©-C ... Patienten mit Alpha1-Antitrypsinmangel (AAT) auf ein Niveau ... normal bezeichneten Bereichs liegt. ATT-Mangel ist eine ...
(Date:5/22/2013)... Israel , May 22, 2013  Rosetta ... developer and provider of microRNA-based molecular diagnostics, announces that ... Chief Executive Officer of Rosetta Genomics, will deliver a ... place from June 3-6, 2013 in New York City.  ... 4 th at 2:00 p.m. Eastern time. ...
(Date:5/22/2013)... and TORONTO , May 22, ... today that John Mon , Chief Operating ... Conference on Thursday, May 30, 2013 in New ... The Company,s presentation is scheduled to begin at ... webcast. To access the webcast, go to:   http://wsw.com/webcast/marcum/mfs.v/   ...
Breaking Medicine Technology:Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 2Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 3
... 8, 2011 Elekta has collaborated with the National ... Practice Guidelines in Oncology ( NCCN Guidelines ™) into ... users real-time access to NCCN,s evidence-based clinical content directly ... " The NCCN Guidelines are widely ...
... PARK, Calif., June 8, 2011 ForteBio®, Inc., ... the development of biotherapeutic and pharmaceutical products, today ... Anti-Mouse IgG Fc Capture (AMC) biosensor for use ... biosensor enables high-throughput rapid kinetic characterization and screening ...
Cached Medicine Technology:National Comprehensive Cancer Network Guidelines Available in Elekta's MOSAIQ EMR 2ForteBio Introduces New Biosensor for Kinetic Analysis and Screening of Mouse IgG Antibodies 2
(Date:5/22/2013)... Cedar Rapids, IA (PRWEB) May 22, 2013 ... inspirational theatre piece Handicap This! The performance promotes ... pursuing their dreams. The Handicap This! performance will be ... Linn Mar High School auditorium. Tickets for Handicap ... , Handicap This! helps audiences measure the level to ...
(Date:5/22/2013)... Twenty student-led startup companies at Arizona ... an intensive startup accelerator designed to help them execute ... create local jobs as part of ASU’s Edson ... initiative offers approximately 20 student teams up to $20,000 ... to launch their for-profit, more-than-profit or nonprofit ventures. The ...
(Date:5/22/2013)... ANN ARBORA University of Michigan study challenges previous ... League Baseball. , The study, a collaboration between ... and Florida, looks deeper into the controversial argument ... more strikes for pitchers of the same race. ... claim, said Jason Winfree, associate professor of sport ...
(Date:5/22/2013)... 22 (HealthDay News) -- Over the next two decades, ... is expected to more than double, topping more than ... The main factor driving the increase: an aging population. ... the American Stroke Association, was published May 22 in ... strain the health care system," Dr. Bruce Ovbiagele, chairman ...
(Date:5/22/2013)... researchers report that hospitals may be reaping enormous ... by preventable bloodstream infections contracted in their intensive ... reported online in the American Journal of ... ICU patient who develops an avoidable central line-associated ... to care for than a similar infection-free patient. ...
Breaking Medicine News(10 mins):Health News:Handicap This! Comes to Marion, Iowa 2Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 2Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 3Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 4Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 5Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 6Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 7Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 8Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 9Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4
... in Mumbai suffers from backache, caused mainly by the poor ... out by Health India, a New Delhi-based non-profit group, the ... Delhi and 77 percent in Mumbai who use public transport ... ,"Bad roads, overcrowded public transport systems, poor quality of ...
... On the eve of the World AIDS Day (Dec 1), ... to 20,000 HIV infected children, Health Minister Anbumani Ramadoss said ... launching a scheme to provide free ARV treatment for children ... for the paediatric drugs and three to four pharmaceutical companies ...
... of Secondary Education (CBSE) has taken following measures to ... a joyful //experience:- ,(i) Abolition of homework for ... ,(ii) Interesting and meaningful alternative activities to replace the ... ,(iii) Continuous and Comprehensive Evaluation from class ...
... device's track record in the United Kingdom concluded that ... the technology's use at least// for now. The review ... Assessment, the international journal series of the Health Technology ... Research in the United Kingdom. ,An implantable ...
... The Minister of Tourism and Culture Smt. Ambika Soni ... promoting India as a Global Health Care Destination. ... foreign tourist to the country Ministry of Tourism in ... the following measures to promote Medial Tourism: ,i) ...
... a heart attack indicates future heart problems, according to ... edition of the// Journal of the American College of ... of depression after having a heart attack are at ... to undergo new depression-related screening protocols and treatment strategies. ...
Cached Medicine News:Health News:Public Transport Causing Backaches in Delhi, Mumbai 2Health News:Free HIV Treatment to Be Launched for Children 2Health News:Review Urges Restricted Use Of Devices To Keep Heart Patients Alive 2Health News:Review Urges Restricted Use Of Devices To Keep Heart Patients Alive 3Health News:Depression After Heart Attack Means More Heart Problems 2Health News:Depression After Heart Attack Means More Heart Problems 3
The ImagingPlanet 55 mm surgical microscope video adapter: superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical ...
The ImagingPlanet 80 mm surgical microscope video adapter: superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Leica surgical...
The ImagingPlanet 80 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Zeiss surgical micro...
The ImagingPlanet 55 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical micro...
Medicine Products: